Sino Biopharmaceutical Limited is a massive, research-driven multinational pharmaceutical conglomerate headquartered in Hong Kong and operating extensively across mainland China and global markets. The enterprise specializes in the research, development, manufacturing, and distribution of a wide array of therapeutic medicines, focusing particularly on oncology, liver diseases, respiratory conditions, and metabolic care, backed by world-class R&D infrastructure and strategic international partnerships.